Altruist Biologics' Hangzhou Antibody-Drug Conjugate Facility Receives Provincial Regulatory Approval for Segmented Production
- Written by PR Newswire
![]() |
- First antibody-drug conjugate facility to receive three provincial regulatory approvals for segmented manufacturing.
- Demonstrated a unified quality system, strict risk assessment protocols, and compliance with rigorous regulatory requirements from development through commercialization.
HANGZHOU, China, July 8, 2026 /PRNewswire/ -- Altruist...














